The study found that 8 (53%) of the 15 lung cancer cell lines expressed IL-6 mRNA and protein, suggesting that the overexpression of IL-6 may disrupt the cytokine balance and weaken the anti-tumor immunity of patients with lung cancer (Yamaji et al., 2004). This evidence concerns the gene IL6 and neoplasm.